Each medication is prepared by licensed 503A compounding pharmacies using pharmaceutical-grade ingredients and sterile preparation protocols
Lilly is positioning retatrutide as an option for patients seeking more significant weight loss than what can be achieved with the available GLP-1 therapies
Obesity rates have almost tripled since 1975, which researchers say is due to a combination of factors, including: Increased access to energy-dense food coupled with reduced physical activity Sleep deprivation Circadian desynchronization Chronic stress A rise in the use of certain medications known to result in weight gain, including some anti-epileptic and psychotropic drugs Other genetic and environmental factors As a result, prescription drug companies have sought their own way to target the treatment of obesity
Hormones, appetite signaling, stress, sleep, insulin resistance, and inflammation all play a role
2005 Mar;47(3):185-9
Frequently Asked Questions (FAQ) Yes, for most patients